Interim Management Statement

Kings Arms Yard VCT PLC Interim Management Statement Introduction I am pleased to present Kings Arms Yard VCT PLC's interim management statement for the period from 1 January to 16 May 2011 as required by the UK Listing Authority's Disclosure and Transparency Rule 4.3. Performance and dividends The Company's unaudited net asset value (NAV), based on management accounts, as at 31 March 2011 was £18.20 million (31 December 2010: £18.28 million) or 16.5 pence per share (31 December 2010: 16.6 pence per share). The current NAVs and comparative figures are calculated before accounting for the dividend of 0.67 pence per share (total cost: £739,000) which will be paid on 24 June 2011 to shareholders on the register as at 27 May 2011, subject to agreement by the shareholders at the Annual General Meeting on 16 May 2011. The Company's net asset value has fallen by 0.1 pence per share since 31 December 2010 due to management fees and other expenses incurred, partly offset by an increase in the valuation of the Company's quoted investments. Portfolio The following investments have been made during the period from 1 January 2011 to 16 May 2011: +-----------------------------------+------+-----------------------------------+ |Name |£000's|   | +-----------------------------------+------+-----------------------------------+ |  |   |  | +-----------------------------------+------+-----------------------------------+ |Vivacta Limited (further | 181 |Medical diagnostics company | |investment) | | | +-----------------------------------+------+-----------------------------------+ |Perpetuum Limited (further | 161 |Provider of vibration energy | |investment) | |harvesting | +-----------------------------------+------+-----------------------------------+ Disposals During the period from 1 January 2011 to 16 May 2011, the following quoted shares have been sold: +------------------------+--------------+--------------------+-----------------+ |Name | Cost - £000's| Carrying value at |Proceeds - £000's| | | | 31 December 2010 - | | | | | £000's | | +------------------------+--------------+--------------------+-----------------+ |MediGene AG | 316 | 83 | 88 | +------------------------+--------------+--------------------+-----------------+ |Allergy Therapeutics PLC| 407 | 38 | 72 | +------------------------+--------------+--------------------+-----------------+ Top ten holdings as at 31 March 2011: +-----------------------------+----------------+ | Investment | Carrying value | | | £000's | +-----------------------------+----------------+ | Elateral Holdings Limited | 2,064 | +-----------------------------+----------------+ | UniServity Limited | 1,640 | +-----------------------------+----------------+ | Imagesound plc | 1,632 | +-----------------------------+----------------+ | Level Four Software Limited | 1,321 | +-----------------------------+----------------+ | Cluster Seven Limited | 965 | +-----------------------------+----------------+ | Haemostatix Limited | 870 | +-----------------------------+----------------+ | Workshare Limited | 618 | +-----------------------------+----------------+ | Sift Limited | 611 | +-----------------------------+----------------+ | Vivacta Limited | 596 | +-----------------------------+----------------+ | Perpetuum Limited | 544 | +-----------------------------+----------------+ Material Events and Transactions As mentioned above, a dividend of 0.67 pence per share will be paid on 24 June 2011 to shareholders on the register as at 27 May 2011, subject to agreement by the shareholders at the Annual General Meeting on 16 May 2011. The Company has re-introduced a Dividend Reinvestment Scheme to existing shareholders.  Details of this Scheme can be found in the circular dated 18 April 2011 at www.albion-ventures.co.uk/Our Funds/ Kings_Arms_Yard.html. There have been no further significant events or transactions that the Board is aware of which would have a material impact on the financial position of the Company between 1 January 2011 and 16 May 2011. Further information regarding historic and current financial performance and other useful shareholder information can be found on the Fund's website under www.albion-ventures.co.uk/Our Funds/Kings_Arms_Yard.html Robin Field, Chairman 16 May 2011 For further information please contact: Patrick Reeve, Albion Ventures LLP - tel: 020 7601 1850 This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients. The owner of this announcement warrants that: (i) the releases contained herein are protected by copyright and other applicable laws; and (ii) they are solely responsible for the content, accuracy and originality of the information contained therein. Source: Kings Arms Yard VCT PLC via Thomson Reuters ONE [HUG#1516219]
UK 100